Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps

NCT03960580 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
223
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Optinose US Inc.